Ipca Laboratories decided to sell its Ankleshwar API manufacturing unit for Rs. 22.15 Cr to Suleshvari Pharma Pvt Ltd. This strategic move aims to optimize operations and reduce costs. The unit generated Rs. 50.24 Cr revenue last FY, but the sale is not expected to materially impact business or financials.